Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)

NCT01709942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

NETWORK

Sponsor class

Conditions

PCOS
OHSS
INFERTILITY

Interventions

DRUG: degarelix (long acting GnRH antagonist)
DRUG: cetrorelix 0.25mg

Sponsor

Centre for Endocrinology and Reproductive Medicine, Italy